PROteolysis TArgeting Chimeras (PROTACs) have garnered a lot of attention in recent times for their ability to exploit the cell’s own degradation machinery to irreversibly degrade target proteins.

In this point of view, we discuss how Syngene can help you move your PROTAC programs from hit to lead to the clinic with speed. We are a one-stop solution for all targeted protein degradation (TPD) research requirements across a variety of molecules, including heterobifunctional degraders and molecular glue degraders. Our experience allows us to create a roadmap for X-TACs research programs, supported at each stage by our experienced team of scientists across chemistry and biology.